Hydrochloric Acid

Hydrochloric Acid

SCHEMBL572002

Cl.O.[AlH3].[Zr]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119303600-A N-alkane isomerization catalyst prepared from polyaluminium chloride 润和催化材料(浙江)有限公司 2025-01-14 CN claimed
CN-116799175-A Lithium zirconium chloride and lithium aluminum chloride double-coated graphite composite material and preparation method thereof 晖阳(贵州)新能源材料有限公司 2023-09-22 CN claimed
CN-116632193-A Lithium zirconium chloride and lithium aluminum chloride double-coated graphite composite material and preparation method thereof 湖南拓森新能源有限公司 2023-08-22 CN claimed
US-20090041820-A1 Functional polymer compositions WU MARGARET M 2009-02-12 US claimed
EP-0925783-B1 Skin protection preparation SPIRIG PHARMA AG (CH) 2004-03-31 EP claimed
US-5676936-A INCORPORATING A COMPOUND HAVING A BASIC NITROGEN FUNCTION OR A BASIC OXYGEN FUNCTION CHESEBROUGH-POND'S U.S.A. CO. (US) 1997-10-14 US claimed
EP-0256831-B1 PREPARATION OF ANTIPERSPIRANTS UNILEVER PLC (GB) 1992-10-21 EP claimed
US-4900534-A Preparation of antiperspirants LEVER BROTHERS COMPANY (US) 1990-02-13 US claimed
EP-0256831-A2 Preparation of antiperspirants UNILEVER PLC (GB) 1988-02-24 EP claimed
CN-114650803-B Cosmetic composition in the form of compacted, impact-resistant powder 化工产品开发公司SEPPIC 2025-03-14 CN disclosed
CN-112969920-B Method for assessing the ability of a substance or composition to prevent, slow or eliminate signs of skin or lips aging 化工产品开发公司SEPPIC 2025-02-11 CN disclosed
CN-119185121-A Composition containing aluminum zirconium tetrachlorohydroxide GLY coordination compound and having antibacterial, deodorizing and antiperspirant effects and application thereof 广州特努斯化工有限公司 2024-12-27 CN disclosed
CN-115151237-B Stable perfuming compositions with good spray characteristics 化工产品开发公司SEPPIC 2024-11-19 CN disclosed
CN-114206308-B Anhydrous composition for topical use in the form of a dispersed phase based on at least one short glycol in a continuous fatty phase 化工产品开发公司SEPPIC 2024-11-19 CN disclosed
EP-0274267-A1 Cosmetic product UNILEVER PLC (GB) 1988-07-13 EP disclosed
EP-0256831-A2 Preparation of antiperspirants UNILEVER PLC (GB) 1988-02-24 EP disclosed
US-4659564-A PERSPIRATION-ABSORBING POLYMERS LEVER BROTHERS COMPANY (US) 1987-04-21 US disclosed
EP-0154465-A2 Skin treatment product UNILEVER PLC (GB) 1985-09-11 EP disclosed
US-4417995-A CATIONIC SOFTENORS, INORGANIC POLYMERS LEVER BROTHERS COMPANY (US) 1983-11-29 US disclosed
EP-0063899-A2 Fabric conditioning composition UNILEVER N.V. (NL) 1982-11-03 EP disclosed